JP2020524719A5 - - Google Patents

Download PDF

Info

Publication number
JP2020524719A5
JP2020524719A5 JP2020520840A JP2020520840A JP2020524719A5 JP 2020524719 A5 JP2020524719 A5 JP 2020524719A5 JP 2020520840 A JP2020520840 A JP 2020520840A JP 2020520840 A JP2020520840 A JP 2020520840A JP 2020524719 A5 JP2020524719 A5 JP 2020524719A5
Authority
JP
Japan
Prior art keywords
oxo
carboxamide
tetrahydroquinazoline
trifluorobenzyl
dimethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020520840A
Other languages
English (en)
Japanese (ja)
Other versions
JP7296954B2 (ja
JP2020524719A (ja
Filing date
Publication date
Priority claimed from GB1709959.9A external-priority patent/GB2563642A/en
Application filed filed Critical
Priority claimed from PCT/GB2018/051730 external-priority patent/WO2018234808A1/en
Publication of JP2020524719A publication Critical patent/JP2020524719A/ja
Publication of JP2020524719A5 publication Critical patent/JP2020524719A5/ja
Application granted granted Critical
Publication of JP7296954B2 publication Critical patent/JP7296954B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020520840A 2017-06-22 2018-06-21 ヒトstingの小分子調節因子 Active JP7296954B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB1709959.9A GB2563642A (en) 2017-06-22 2017-06-22 Small molecule modulators of human STING
GB1709959.9 2017-06-22
IN201711021858 2017-06-22
IN201711021858 2017-06-22
IN201811014462 2018-04-16
IN201811014462 2018-04-16
PCT/GB2018/051730 WO2018234808A1 (en) 2017-06-22 2018-06-21 MODULATORS WITH SMALL MOLECULES OF STING HUMAIN

Publications (3)

Publication Number Publication Date
JP2020524719A JP2020524719A (ja) 2020-08-20
JP2020524719A5 true JP2020524719A5 (enExample) 2021-07-26
JP7296954B2 JP7296954B2 (ja) 2023-06-23

Family

ID=62816874

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020520840A Active JP7296954B2 (ja) 2017-06-22 2018-06-21 ヒトstingの小分子調節因子

Country Status (20)

Country Link
US (1) US11571423B2 (enExample)
EP (1) EP3642198B1 (enExample)
JP (1) JP7296954B2 (enExample)
KR (1) KR102628892B1 (enExample)
CN (1) CN111132972B (enExample)
AR (1) AR114975A1 (enExample)
AU (1) AU2018288018C1 (enExample)
CA (1) CA3067257A1 (enExample)
CL (1) CL2019003793A1 (enExample)
CO (1) CO2020000562A2 (enExample)
EC (1) ECSP20004580A (enExample)
IL (1) IL271522B2 (enExample)
MX (1) MX2019015468A (enExample)
PE (1) PE20200696A1 (enExample)
PH (1) PH12019502870A1 (enExample)
SG (1) SG11201912397RA (enExample)
TW (1) TWI799426B (enExample)
UA (1) UA125730C2 (enExample)
WO (1) WO2018234808A1 (enExample)
ZA (1) ZA201908496B (enExample)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3029644A1 (en) 2016-07-06 2018-01-11 Sperovie Biosciences, Inc. Compounds, compositions, and methods for the treatment of disease
CN111132972B (zh) 2017-06-22 2024-07-12 克拉德夫制药有限公司 人sting的小分子调节剂
GB2574913A (en) * 2017-06-22 2019-12-25 Curadev Pharma Ltd Small molecule modulators of human STING, conjugates and therapeutic applications
EP3675859A4 (en) 2017-08-31 2021-06-30 Sperovie Biosciences, Inc. COMPOUNDS, COMPOSITIONS AND PROCEDURES FOR TREATMENT OF DISEASES
US11707531B2 (en) 2017-09-11 2023-07-25 F-star Therapeutics, Inc. Compounds, compositions, and methods for the treatment of disease
WO2019051488A1 (en) 2017-09-11 2019-03-14 Sperovie Biosciences, Inc. COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISEASE
CN112135825A (zh) 2018-03-13 2020-12-25 夏尔人类遗传性治疗公司 血浆激肽释放酶抑制剂及其用途
GB201807924D0 (en) 2018-05-16 2018-06-27 Ctxt Pty Ltd Compounds
EP3802534B1 (en) 2018-05-25 2022-07-13 Incyte Corporation Tricyclic heterocyclic compounds as sting activators
WO2020014127A1 (en) 2018-07-10 2020-01-16 Sperovie Biosciences, Inc. Compounds, compositions, and methods for the treatment of disease
WO2020028565A1 (en) 2018-07-31 2020-02-06 Incyte Corporation Tricyclic heteraryl compounds as sting activators
US10875872B2 (en) 2018-07-31 2020-12-29 Incyte Corporation Heteroaryl amide compounds as sting activators
US11596692B1 (en) 2018-11-21 2023-03-07 Incyte Corporation PD-L1/STING conjugates and methods of use
WO2020146237A1 (en) 2019-01-07 2020-07-16 Incyte Corporation Heteroaryl amide compounds as sting activators
CN119455003A (zh) 2019-02-12 2025-02-18 Ambrx公司 包含抗体-tlr激动剂缀合物的组合物、方法和用途
KR20210146370A (ko) 2019-03-28 2021-12-03 루핀 리미티드 Sting 효능제로서의 매크로사이클릭 화합물
JP7531508B2 (ja) * 2019-04-30 2024-08-09 シチュアン ケルン-バイオテック バイオファーマシューティカル カンパニー リミテッド ベンゾチオフェン化合物、その調製方法およびその使用
MA55805A (fr) 2019-05-03 2022-03-09 Flagship Pioneering Innovations V Inc Métodes de modulation de l'activité immunitaire
MX2021015188A (es) * 2019-06-12 2022-01-18 Ryvu Therapeutics S A Moduladores de nueva generacion del estimulador de genes de interferon (sting).
MA56193A (fr) * 2019-06-14 2022-04-20 Ifm Due Inc Composés et compositions pour traiter des états associés à une activité de sting
WO2021007160A1 (en) 2019-07-05 2021-01-14 Tambo, Inc. Trans-cyclooctene bioorthogonal agents and uses in cancer and immunotherapy
GB201910304D0 (en) 2019-07-18 2019-09-04 Ctxt Pty Ltd Compounds
GB201910305D0 (en) 2019-07-18 2019-09-04 Ctxt Pty Ltd Compounds
DK4004002T3 (da) 2019-07-22 2024-09-30 Lupin Ltd Makrocykliske forbindelser som sting-agonister samt fremgangsmåder og anvendelser dermed
WO2021055589A1 (en) 2019-09-18 2021-03-25 Shire Human Genetic Therapies, Inc. Heteroaryl plasma kallikrein inhibitors
CN114728962B (zh) 2019-09-18 2025-09-19 武田药品工业有限公司 血浆激肽释放酶抑制剂及其用途
PH12022550709A1 (en) 2019-09-25 2023-03-27 Pfizer Polyheterocyclic modulators of sting (stimulator of interferon genes)
CN114787148A (zh) 2019-12-11 2022-07-22 雷沃医疗有限公司 官能化杂环化合物作为干扰素基因刺激物(sting)的调节剂
KR20260022465A (ko) 2019-12-11 2026-02-19 리부 세라퓨틱스 에스.에이. 인터페론 유전자 자극제(sting)의 조절제인 헤테로사이클릭 화합물
WO2021119753A1 (en) 2019-12-18 2021-06-24 Ctxt Pty Limited Compounds
EP4103278A1 (en) * 2020-02-12 2022-12-21 Curadev Pharma Pvt. Ltd. Small molecule sting antagonists
US20230141284A1 (en) 2020-04-10 2023-05-11 Ono Pharmaceutical Co., Ltd. Cancer therapeutic method
US20230192631A1 (en) * 2020-04-16 2023-06-22 Hoffmann-La Roche Inc. Biphenyl Derivatives
IL298019A (en) 2020-05-13 2023-01-01 Massachusetts Inst Technology Compositions of polymeric microdevices and their use in cancer immunotherapy
JP2023537066A (ja) 2020-08-07 2023-08-30 タンボ・インコーポレイテッド トランス-シクロオクテン生体直交型薬剤並びに癌及び免疫療法における使用
JP2024502474A (ja) 2021-01-08 2024-01-19 アイエフエム デュー インコーポレイテッド Sting活性に関連する状態を治療するための、尿素を有するヘテロ二環式化合物または類似体およびその組成物
WO2022169921A1 (en) * 2021-02-04 2022-08-11 Bristol-Myers Squibb Company Benzofuran compounds as sting agonists
US11964978B2 (en) * 2021-03-18 2024-04-23 Pfizer Inc. Modulators of STING (stimulator of interferon genes)
CN117321055A (zh) * 2021-03-18 2023-12-29 辉瑞公司 Sting(干扰素基因刺激剂)的调节剂
ES3066682T3 (en) * 2021-08-11 2026-05-14 Curadev Pharma Pvt Ltd Small molecule urea derivatives as sting antagonists
CA3228528A1 (en) 2021-08-11 2023-02-16 Monali BANERJEE Small molecule sting antagonists
WO2023147597A2 (en) * 2022-01-31 2023-08-03 The Board Of Regents Of The University Of Texas System Allosteric sting modulators and methods of use
EP4530282A4 (en) * 2022-04-28 2026-05-06 Sds Biotech Corp ANILIDE HALOALKYLSULPHONE COMPOUND AND HERBICIDE THE CONTAINER
CN115015310B (zh) * 2022-05-23 2024-12-10 宁波大学 一种巯基化合物的分析方法
CN114805309A (zh) * 2022-06-07 2022-07-29 中国药科大学 苯并杂环类化合物及其制备方法、药物组合物和应用
WO2024211577A1 (en) 2023-04-05 2024-10-10 Massachusetts Institute Of Technology Hybrid polymeric systems and methods of use thereof
CN119330982A (zh) * 2023-07-19 2025-01-21 中国科学院上海药物研究所 氮杂环丁烷类化合物及其医药用途
WO2026078593A1 (en) 2024-10-08 2026-04-16 Sun Pharma Advanced Research Company Limited Sting agonists and antibody drug conjugates thereof

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
AU661533B2 (en) 1992-01-20 1995-07-27 Astrazeneca Ab Quinazoline derivatives
US5783577A (en) 1995-09-15 1998-07-21 Trega Biosciences, Inc. Synthesis of quinazolinone libraries and derivatives thereof
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
WO2000035298A1 (en) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Chewing gum containing medicament active agents
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
PL343112A1 (en) 1998-03-31 2001-07-30 Warner Lambert Co Quinolones as serine protease inhibitors
GB0225833D0 (en) 2002-11-06 2002-12-11 Univ Leeds Nucleic acid ligands and uses therefor
US7417052B2 (en) 2004-09-29 2008-08-26 Sankyo Company, Limited Phenylene derivative having tetrazole ring or thiazolidinedione ring
US7601716B2 (en) * 2006-05-01 2009-10-13 Cephalon, Inc. Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors
CA2656507C (en) * 2006-07-17 2012-03-20 Amgen Inc. Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors
AR063302A1 (es) 2006-10-13 2009-01-21 Otsuka Pharma Co Ltd Derivados de 4-benzo[b]tiofen-4-il-piperazin-1-il con accion antagonista del receptor 5-ht2a de serotonina y receptor de adrenalina alfa1 y agonista parcial del receptor d2, una composicion farmaceutica que lo comprende y un proceso para producirla.
RU2497819C2 (ru) 2007-05-21 2013-11-10 Ривайва Фармасьютикалс, Инк. Композиции, синтез и способы применения атипичных нейролептиков на основе хинолина
US9315449B2 (en) 2008-05-15 2016-04-19 Duke University Substituted pyrazoles as heat shock transcription factor activators
TW201030007A (en) 2009-02-06 2010-08-16 Gruenenthal Gmbh Substituted spiro-amides as b1r modulators
GB0922589D0 (en) * 2009-12-23 2010-02-10 Almac Discovery Ltd Pharmaceutical compounds
AP2013007331A0 (en) 2011-06-24 2013-12-31 Amgen Inc TRPM8 antagonists and their use in treatments
RU2014149136A (ru) 2012-05-08 2016-07-10 Мерк Шарп И Доум Корп. ТЕТРАГИДРОНАФТИРИДИНОВЫЕ И РОДСТВЕННЫЕ БИЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ ДЛЯ ИНГИБИРОВАНИЯ RORγ АКТИВНОСТИ И ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ
JP2016147807A (ja) 2013-06-04 2016-08-18 日本理化学工業株式会社 ヒドロキサム酸誘導体またはその塩
AU2015315174B2 (en) 2014-09-10 2019-12-12 Epizyme, Inc. Smyd inhibitors
AR105911A1 (es) 2015-09-03 2017-11-22 Forma Therapeutics Inc Inhibidores de hdac8 bicíclicos fusionados [6,6]
US20170146519A1 (en) * 2015-11-20 2017-05-25 Oregon Health & Science University Sting agonists and methods of selecting sting agonists
GB2572526A (en) * 2017-06-22 2019-10-09 Curadev Pharma Ltd Heterocyclic small molecule modulators of human STING
GB2563642A (en) 2017-06-22 2018-12-26 Curadev Pharma Ltd Small molecule modulators of human STING
CN111132972B (zh) 2017-06-22 2024-07-12 克拉德夫制药有限公司 人sting的小分子调节剂
JP2020524718A (ja) 2017-06-22 2020-08-20 キュラデブ・ファーマ・リミテッドCuradev Pharma Limited ヒトstingの複素環式小分子調節因子
US20200138827A1 (en) 2017-06-22 2020-05-07 Curadev Pharma Limited Small molecule modulators of human sting
WO2019243825A1 (en) 2018-06-21 2019-12-26 Curadev Pharma Limited Small molecule modulators of human sting, conjugates and therapeutic applications

Similar Documents

Publication Publication Date Title
JP5656874B2 (ja) Pde9阻害剤として使用されるアミノヘテロ環化合物
JP6218260B2 (ja) Jak阻害剤としてのアミノピリミジニル化合物
TWI500616B (zh) 新穎之雙環吡啶酮
RU2007101654A (ru) Производные пиридазин-3(2h)-она и их применение в качестве ингибиторов фдэ4
JP2009544600A5 (enExample)
RU2013105490A (ru) Спироциклические аминовые производные в качестве модуляторов s1p
JP2005504080A5 (enExample)
JP2007523152A5 (enExample)
JP2007518822A5 (enExample)
TW201920120A (zh) 人類sting之小分子調節調
RU96111418A (ru) ПРОИЗВОДНЫЕ ПИРИМИДИНДИОНА, ПИРИМИДИНТРИОНА, ТРИАЗИНДИОНА, ТЕТРАГИДРОХИНАЗОЛИНДИОНА В КАЧЕСТВЕ АНТАГОНИСТОВ α1 АДРЕНЕРГИЧЕСКИХ РЕЦЕПТОРОВ
JP2017531679A (ja) キナーゼ阻害剤として有用なインドールカルボキシアミド
JP2009513703A5 (enExample)
JP2017525757A5 (enExample)
RU2009136299A (ru) Новые производные 3-({1,2,4}триазоло{4,3-а}пиридин-7-ил)бензамида
JP2018508535A (ja) ベンザゼピンジカルボキサミド化合物
JP2005533868A5 (enExample)
JP2001526222A5 (enExample)
JP2017511794A5 (enExample)
JP2008535803A5 (enExample)
JP2016507581A (ja) Cnsおよび他の障害を治療するための、pde4アイソザイムの阻害薬としてのアザベンゾイミダゾール化合物
JP2023537630A5 (enExample)
US20170166566A1 (en) SUBSTITUTED PYRIDO[1,2-a]PYRAZINES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
JP2022522312A (ja) ピロール化合物
JP2016511262A (ja) 置換二環式ジヒドロピリミジノン及び好中球エラスターゼ活性の阻害薬としてのそれらの使用